Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

<< Previous

Bullboard Posts

Next >>

Post by edroseon Jun 05, 2021 8:40pm

153 Views

Post# 33336698

Why would a company sell for peanuts their best asset and ip

Few weeks before fda decision

and state we will concentrate on small molecule division THE FEW WEEKS later state pk data is poor and we stop all research re 4050.

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project